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Development of reduction-responsive degradable 
polylactide-based amphiphilic block copolymers 
for drug-delivery applications. 
Alexander J. Cunningham 
 Ubiquitous in nature as a result of their versatility both in their structure 
and properties, smart polymers have been the subject of intensive research in the 
design of synthetic materials in the field of biomedicine. Of notable consideration, 
these polymers as drug delivery vehicles offer the potential to increase the 
bioavailability of therapeutic molecules while reducing the side effects 
customarily associated with small molecule delivery.  
Amphiphilic block copolymers (ABPs) bear a hydrophobic block 
comprising the hydrophobic core of the nanostructure, and a hydrophilic block 
providing colloidal stability. The ABP-based micellar carriers are endowed with 
great advantages that include, but are not limited to, the use of biocompatible 
material in their synthesis, thereby avoiding adverse side effects from the use of 
noxious materials. Moreover, the material can be synthesized using facile 
synthetic methods that allow a narrow size distribution and versatility in their 
physicochemical properties. Furthermore, their chemical flexibility in their design 
allows for the incorporation of targeting ligands at the hydrophilic corona 
promoting active targeting into specific cells. Another point to consider is the 
incorporation of dynamic chemical bonds in the architecture of the delivery 
vehicle to promote spatio-temporal release of the encapsulated cargo. Known as 
stimuli-responsive degradation (SRD), this concept has been exercised to take 
advantage of endogenous cellular triggers such as gradients in redox potential, pH 
or temperature that exists among different sub-cellular organelles as well as in 
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different cell types/states; e.g. healthy vs. cancerous cells. One such promising 
stimuli-responsive platform is the disulfide-thiol chemistry.  
In addition, polylactide, a hydroxyalkanoic acid-based hydrophobic 
polyester, is a promising material in the synthesis of ABPs for biomedical 
applications. Indeed, it is biocompatible, biodegradable, FDA-approved, and has 
tunable mechanical properties. However, two challenges remain to be resolved 
before a successful polylactide-based drug delivery system can be developed: 1) 
its inherent hydrophobicity; 2) its slow degradation. In this thesis, potential 
solutions are examined. 
 This research is based on the development of monocleavable thiol-
responsive degradable polylactide-based amphiphilic block copolymers for drug 
delivery applications. Different synthetic strategies for the preparation of 
disulfide-labeled ABPs are presented using either a methacrylate-based or an 
ethylene oxide-based hydrophilic block. These ABPs are synthesized by a 
combination of ring-opening polymerization with either atom-transfer radical 
polymerization or a facile coupling reaction. They are amphiphilic and thus self-
assemble to form colloidaly stable micellar aggregates in aqueous solutions above 
their critical micellar concentration (CMC). These drug loaded ABPs were tested 
for drug delivery by studying the extent of drug loading and release through 
analytical methods. Results suggest the disulfide-labeled ABPs respond to the 
presence of a reducing agent by releasing the encapsulated drug providing support 
for their potential as delivery vehicles for the targeted release of loaded drugs in 
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Chapter 1 Introduction 
 
1.1 Overview of research and goals 
The goal of my master`s research is to explore novel methods for the synthesis 
of disulfide-labeled amphiphilic block copolymers (ABP) that can be useful as 
effective building blocks to fabricate drug delivery vehicles exhibiting 
controlled/enhanced release of anti-cancer drugs in specific tissues. Specifically, 
two polylactide (PLA)-based monocleavable amphiphilic triblock copolymers 
with a disulfide linkage in the middle of the hydrophobic block were designed to 
study the impact of architectural morphology on reduction-responsive degradation 
and concomitant drug release. These monocleavable PLA-based ABPs were 
synthesized by ring-opening polymerization (ROP) combined with either atom-
transfer radical polymerization (ATRP) or a facile coupling reaction. They self-
assembled into micellar aggregates having disulfides in their hydrophobic core, 
allowing the encapsulation of hydrophobic drugs, and surrounded with 
hydrophilic coronas, ensuring colloidal stability. The reductive cleavage of the 
disulfide linkages resulted in a change in the morphology of micellar aggregates 
as well as an enhanced release of encapsulated anti-cancer drugs.  
1.2 Drug delivery general understanding and goals 
 In the treatment of various diseases, small therapeutics are chemically 
synthesized to remedy the function of diseased enzyme or state. Almost 60 years 
ago Sidney Farber successfully conducted the first clinical trial for a 
chemotherapeutic agent against a tumor.
[1]
 Unfortunately, these small therapeutics 
displayed various side effects and limitations. One commonly associated side 
effect encountered in chemotherapy is the nonspecific toxicity.
[2]
 On one hand, 
 2 
 
these molecules often target general cellular pathways common to every cell in 
the organism; on the other hand these molecules are small enough to pass through 
endothelial cells and gain access to various tissues thereby causing toxic 
responses in healthy tissues. A promising solution is to construct effective drug 
delivery systems that can prevent the nonspecific toxicity associated with 
traditional small molecule therapies.
[2-3]
   
1.3 Polymer-based drug delivery applications 
1.3.1 Characteristics of polymer-based drug delivery 
 In order to circumvent the toxicity associated with small molecule therapy, 
drug delivery vehicles has been proposed as a means to encapsulate these drug 
molecules and deliver them safely and efficiently to the targeted tissue. Building 
on the idea of the magic bullet, proposed by Paul Erlich, numerous devices have 
been designed to incorporate hydrophobic drugs effectively shielding it during 
transportation throughout the blood stream.
[4]








 and polymer based nanoparticles.
[8]
 Particularly, polymer-
based nanoparticles have displayed superior advantages in some regards; notably 
in the sense that they can be prepared from biocompatible materials that limits 
issues of compliance between the synthetic material and the physiological milieu; 
have a wide range of structures that can be obtained; and have tunable chemical 
and physical properties.
[9]
 The advantages that delivery systems can confer to the 
small therapeutics include 1) protection of therapeutics during blood circulation 
thereby avoiding possible deactivation through enzymatic reactions or other 
interactions; 2) enhanced uptake into targeted cells through incorporation of 
targeting ligands for receptor-mediated endocytosis; 3) avoidance of renal 
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clearance; 4) increased biodistribution and circulation time thereby increasing the 
likelihood of the drug to reach the targeted tissue.  
1.3.2 Shapes and structures of polymer-based drug delivery systems 
 Figure 1.1 shows different types of polymer-based drug delivery systems 












Figure 1.1. Different types of polymer-based DDS.  
 
Polymer-drug conjugate 
Drug Degradable Linker Hydrophilic Polymer 
Dendrimers 
Block copolymer aggregates Microgel/Nanogel 
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 Polymer-drug conjugates, also referred to as polymer prodrugs, are an 
inactive form of a drug conjugated to a polymer where the drug is converted back 
to its active form upon cleavage of the bond that links the polymer to the drug.
[7b]
 
These polymers increase the water solubility of the drug, therefore enhancing 
their bioavailability. Moreover, they serve to protect the drug from deactivation 
and preserve its activity, while promoting cellular internalization through the use 
of ligands conjugated to the ends of the polymer.
[10]
 In addition, the use of 
covalent bonds that may be enzymatically cleaved in specific cellular 
environment allows for the selective release of the drug. However, polymer-drug 
conjugates have a common limitation: the presence of various reactive groups on 
the drugs thereby complicating the conjugation task.
[7b]
  
 Similarly, dendrimers, highly branched macromolecules with many arms 
emanating from a core, offer promising properties for drug delivery 
applications.
[11a]
 Prepared by a stepwise synthesis, they are composed of a highly 
regular branching pattern as opposed to the hyperbranched polymers 
characterized by irregular branching, albeit readily accessed by various facile 
polymerization strategies. On one hand, these structures offer certain advantages 
that include a multivalent architecture enabling the attachment of several drugs, 
targeting groups, and solubilizing groups in a well-defined manner.
[11b]
 Moreover, 
their low-polydispersity in their synthesis allows for a batch-to-batch 
reproducibility which translates into reproducible pharmacokinetics. On the other 
hand, they suffer from inadequate drug release, when using enzymatically 
cleavable linkages, from these nanocarriers due to the steric hindrance.
[11a]
 Their 
biodistribution is also challenging whereby issues in generating structures marked 




 Hydrogels have also shown drug delivery applications. Either referred to 
as microgels, for micrometer-sized hydrogels or nanogels for nanometer-sized 
hydrogels, they are made up of water-soluble polymers that adopt a three-
dimensional cross-linked network.
[12a]
 They have various assets that justify their 
use in drug delivery; namely, a highly porous network which can be easily tuned 
by varying the amount of crosslinks. The porous structure of the hydrogels allows 
for loading of drugs into the gel matrix and their subsequent release which 
becomes limited by the rate of diffusion of these molecules throughout the pore 
network.
[12b]
 Therewith, they can also be prepared from biocompatible materials 
and be designed to be biodegradable through the incorporation of stimuli-
responsive groups. However, they also suffer from certain drawbacks: such as 
limitations in quantity and heterogeneity of drugs which may be loaded. Indeed, 
due to their high water content loading of hydrophobic drugs may be hindered.
[12b]
 
Moreover, their high porosity entails a rapid drug release which may be unwanted 
for certain applications.  
My thesis work includes mainly ABP-based nanocarriers for drug delivery 
applications.  
1.3.3 ABP-based drug delivery nanocarriers  
 As illustrated in Figure 1.2, ABPs are block copolymers which are 
composed of two or more covalently linked blocks that bear hydrophobic and 
hydrophilic properties. These block copolymers assemble into aggregates in 
aqueous solutions; the hydrophobic block constituting the core and the 
hydrophilic block the corona, thereby providing colloidal stability to the 
aggregates. Governed by an enthalpy driven process,
[14]
 the resulting self-
assembled aggregates exist in various morphologies, such as spheres, elongated 
spheres, rods, tubules, lamellae, and vesicles.
[13]
 Their shape and size depends on 
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the balance of three forces acting on the system: 1) the constraints on the core-
forming block (the block being stretched or contracted depending on the solvent); 
2) the interaction between the corona-forming blocks; 3) the energy at the 
interface between the solvent and the core-forming block.
[15]
 These forces are 
balanced by a number of morphological parameters which typically include block 
copolymer composition, copolymer concentration, temperature, copolymer 




Figure 1.2. An illustration of aqueous self-assembly of ABPs into different 
aggregates. 
1.3.4 Micellization of ABP  
The topic of my master's research deals with the formation of spherical 
micelles, also referred to as micellar aggregates, for drug delivery applications, 
consequently this discussion is focused on the formation of micellar aggregates in 
aqueous solution. Governed by thermodynamics, micelles form when the 
concentration of amphiphilic block copolymers is above a certain concentration, 
known as the critical micellar concentration (CMC) and below a specific 
temperature, known as the critical micellar temperature (CMT).
[14b, 15]
 When these 











exist as unimers in aqueous solution. However, above a certain concentration the 
enthalpic cost arising from the contact of the hydrophobic block and the aqueous 
solution overcomes the entropic cost resulting in the aggregation of these ABP 
unimers in order to minimize the contact between the hydrophobic block and the 
aqueous solution.
[14b]
 However, this phase separation is counter balanced by the 
repulsive forces in the hydrophilic blocks since these extend to hydrate 
themselves maximally. This equilibrium between these two forces generates these 
micellar structures that all have a certain curvature. If the concentration of these 
ABPs is further increased towards the semi-dilute to high concentrations, an 
arrangement of these micelles into an ordered state is obtained which leads to the 
process known as gelation.
[16]
 Specifically for spherical micelles, there exist two 
types of micelles, crew-cut micelles and star-like micelles.
[16]
 In the case of star-
like micelles, the insoluble block is smaller than the soluble block and the 
resulting micelles have a small core and a long corona. Conversely, in the crew-
cut micelles the core forming block is longer than the hydrophilic block such that 
the core is large and the corona is short.  
 Micelles are characterized by their thermodynamic and kinetic stability. 
The thermodynamic stability of a micelle pertains to its stability relative to its 
disassembly into single chains in solution.
[15]
 On the other hand, upon dilution of 
the micelles below the CMC value, the micelles remain stable for some time 
before disassembling. Referred to as kinetic stability, this phenomenon depends 
on factors such as the physical state of the micelle core, where micelles formed by 
a hydrophobic block that has a high Tg will tend to disassemble more slowly.
[15]
 
Also, the length of both blocks, as well as the presence of hydrophobic molecules 
in the core affects this stability, where a micelle composed of an ABP with a large 
hydrophobic/hydrophilic ratio is portrayed with a lower rate of disassembly.  
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In the field of drug delivery application, the CMC is an important feature 
that impacts the propensity of the drug delivery system towards a successful 
application. Upon injection of a drug-loaded ABP in the human body a large 
volume of dilution arise. The average blood volume in an individual is 
approximately 5 L. If, for example, 100 mL of a 2.5% (w/w) micelle solution is 
injected, the concentration of the micelle solution falls to 0.5 mg/mL. 
Consequently, an ABP system with a low CMC is desired for drug delivery 
applications. Many factors govern the CMC, most notably the nature and length 
of the core-forming block, the length of the hydrophilic block, and the presence of 
hydrophobic solubilizates, such as hydrophobic therapeutic drugs.  
1.3.4.1 Micelle size  
In addition to surface charge and nature of hydrophilic corona, the size of 
micelles is an important characteristic with regards to drug delivery applications. 
The size of these ABP-based micelles can impact their circulation time and their 
biodistribution in the human body.
[1]
 Particles circulating in the blood stream have 
their fate determined partly by their size. Particles that are larger than 200 nm are 
recognized by the reticulo-endothelial system (RES) and removed by 
macrophages, dendritic cells, or neutrophils.
[17]
 Moreover, pertaining to drug 
delivery towards anti-cancer applications, the fenestrae of endothelial cells lining 
the blood vessels in tumor tissues are characterized with larger gaps than that in 
healthy tissues.
[18]
 In addition, these tumor tissues are also characterized with poor 
lymphatic drainage due to poor development of a lymphatic system surrounding 
these tissues.
[19]
 This increase in gap size for these endothelial cells lining the 
blood vessels and improper lymphatic drainage gives rise to a phenomenon 
referred to as the enhanced permeability and retention effect (EPR).
[20]
 EPR, a 
passive and only targeting means in blood circulation, forms the basic mechanism 
by which nanoparticles escape from the blood circulation and enter these tumor 
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tissues. The large gaps between endothelial cells in the tumor vasculature allow 
large nanoparticles to escape the blood circulation, while the improper lymphatic 
drainage causes accumulation of these nanoparticles in the tumor tissue (Figure 
1.3). As a result, this presents an advantage for targeting cancer cells since 
nanoparticles are designed to be large enough to avoid penetration in healthy 
tissues, but small enough to pass through these gaps in tumor blood vessels.  
 
Figure 1.3. Drug accumulation into cancer tissues arising from the enhanced 
permeation and retention effect (EPR).
[21]
 
1.3.5 Micelle preparation 
To prepare these micelles into nanoparticles, various methods have been 
developed and they are an essential part for optimal delivery. The preparation 
methods fall within two categories: the one-step and two-step nanoparticle (NP) 
formation. In the one-step approach, an organic solution that contains the ABP 
and the drug is added drop-wise to an aqueous solution under stirring. The 
aggregates are formed instantly as polymer diffuse into the aqueous phase.
[22]
 In 
this method, the organic and aqueous solutions are miscible. The parameters that 
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govern the particle size are the miscibility of the two solutions, the rate of 
addition, and the stirring speed.
[23]
 Typically, aggregates formed through this 
method are smaller than the other methods, and this process may be applied to a 
wide range of materials.
[22]
 For the two-step NP formation, there exist three 
different types of preparation methods; emulsification-solvent evaporation, 
emulsification-solvent diffusion, and emulsification-salting out. These methods 
rely on the formation of an oil-in-water emulsion. Here, the polymer and the 
drugs are dissolved in the organic phase, which appear as emulsion droplets, and 
the subsequent removal of the organic phase drives the formation of the 
nanoparticles. Depending on the emulsification process, the size and drug loading 
of the nanoparticles varies. However, in these preparation methods the drug 
loading are usually lower than for the one-step approach.
[22]
  
In the emulsification-solvent evaporation technique, the most common 
preparation method for NPs, the solvent is removed through evaporation under 
reduced pressure following emulsification.
[23]
 As the solvent evaporates the NPs 
are formed. This method is typically used for the encapsulation of lipophilic drugs 
and the size of the nanoparticles is influenced by the coalescence of emulsion 
droplets. In the emulsification-solvent diffusion technique, the organic phase, 
which is partially water-miscible, is removed through diffusion from the emulsion 
droplets into the water phase. In this method, due to the fast diffusion of the 
organic phase the physical properties of the NPs produced are reproducible and 
generally this method produces NPs with an average diameter of 150 nm.
[23]
 In 
the emulsification-salting out method, the organic solvent used is totally water-
miscible. However, the aqueous phase is saturated with a salt which prevents the 
mixing of the organic phase and the aqueous phase enabling the emulsion to 
form.
[22]
 Then, the organic phase is removed by dilution with water which reduces 
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the salt concentration and allows mixing of the two phases. Typically, this method 
produces NPs that are smaller, but with lower encapsulation efficiency.
[24]
  
1.4 Stimuli-responsive copolymers in drug delivery 
 In light of the previous sections, ABP-based DDS possess a number of 
advantages towards successful drug-delivery applications; these include low 
colloidal stability (low CMC), tunable and narrow size distribution, protection of 
drugs from possible deactivation during blood circulation, high loading efficiency 
of the drug without further chemical modifications, and bioconjugation of the 
delivery vehicle for targeted delivery in tissues or organs as well as cellular 
internalization. However, an ongoing challenge involve controlled/enhanced 
release of encapsulated biomolecules for DDS in targeted cancer cells after 
cellular uptake (i.e. endocytosis). A promising solution to circumvent this 
challenge can be found in stimuli-responsive degradation (SRD).
[25]
 This 
promising platform for the efficient release of loaded therapeutic molecules finds 
its mainspring in the incorporation of dynamic covalent bonds in the architecture 
of polymers. These covalent bonds, in response to precise stimuli, are cleaved 
thereby disrupting the integrity of the structural conformation of the polymer. 
Appropriately positioned in the polymer backbone, these covalent bonds can 
cause disruption of the integrity of nanoparticles formed from these polymers in 
response to the stimuli, leading to the release of encapsulated drugs (Figure 1.4). 
Moreover, the incorporation of SRD allows for a morphological control on the 




Figure 1.4. Stimuli-responsive degradation for the spatio-temporal release of 
encapsulated therapeutic drugs for block copolymer-based nanocarriers. 
1.4.1 Stimuli-responsive covalent linkages 
There exist numerous types of stimuli-responsive covalent bonds where 
the stimuli-responsive polymer undergoes physical or chemical changes in 
response to the stimuli. For example, acid-labile acetals, orthoesters, imine, and 
hydrazone linkages can be cleaved in acidic pH.
[26]
 Coumarin dimers, 2-diazo-
1,2-napthoquinone, and o-nitrobenzyl linkages can be cleaved in response to 
light.
[27]
 Moreover, the use of ultrasound-responsive and enzymatically cleaved 
linkages have been explored for their use in drug delivery applications.
[28]
 In my 
master's research, the thiol-responsive disulfide linkage was examined for its 
potential in drug delivery applications for anti-cancer therapeutics.  
 Disulfides are promising in that they are cleaved through a disulfide-thiol 
exchange reaction in the presence of free thiols as reducing agents.
[25, 29]
 In 
biological systems, glutathione (GSH), a tripeptide formed by glutamic acid, 
cysteine and glycine, is a cellular reducing agent that cleaves disulfide linkages, 
and is found at higher concentrations of its reduced state in intracellular 
environments in comparison to the extracellular milieu.
[30]












(X : Cleavable linkage) 
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found at elevated levels in numerous types of cancerous cells through the up-
regulation of the enzyme glutathione disulfide reductase which catalyzes the 
reduction of GS-SG into GSH.
[31]
 Therefore, the reduction-responsive disulfide is 
a promising platform in the construction of reduction-responsive degradable 
ABP-based nanocarriers for tumor-targeted drug delivery applications.  
1.4.2 Approaches to preparation of reduction-responsive micelles at different 
locations 
Disulfide linkages can be positioned at different locations and with 
different quantities in the polymer structure leading to different outcomes upon 
degradation. There are five main categories for the location of these disulfide 
bonds which are presented in Figure 1.5.
[25]
 In general, the main approach to elicit 
the degradation of ABP-based micelles in response to reductive reactions is 




In strategy A, the disulfide linkage is incorporated between the 
hydrophobic and hydrophilic blocks such that in response to free thiols as 
reducing agents the hydrophilic corona is shed from the micelles thereby 
disrupting the colloidal stability and causing the release of the encapsulated 
drug.
[25, 33]
 For example, an ABP-based drug delivery nanocarrier was labeled 
with a disulfide linkage at the interface of hydrophobic polylactide (PLA) and 
hydrophilic poly[oligo(ethylene glycol) monomethyl ether methacrylate] 
(POEOMA) for controlled/enhanced drug release.
[33b]
 These ABPs formed 
colloidally stable micelles with PLA as the core and POEOMA as the corona. 
Thiol-responsive degradation resulted in the shedding of the POEOMA corona 
causing PLA to precipitate, thereby showing their potential as drug delivery 
nanocarriers.   
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Strategy B involves multiple disulfide linkages positioned as pendant 
chains in the hydrophobic block. Upon cleavage of the disulfides, the polarity of 
the hydrophobic block is increased thereby causing the micelles to disintegrate 
which ultimately leads to the release of the loaded drugs.
[34]
  
Strategy C involves multiple cleavable linkages positioned repeatedly in 
the polymer backbone of the hydrophobic block.
[35]
 In response to the stimuli, the 
hydrophobic block becomes destroyed and the micelles are broken down. For 
example, block copolymer micelles composed of a polyester as hydrophobic 
block labeled with repeating stimuli-responsive disulfide linkages, and a 
polymethacrylate as hydrophilic corona were synthesized.
[35a]
 The disulfide 
linkages were cleaved in the presence of thiols to enhance the release of loaded 
molecules.  
  Finally, in strategy D monocleavable ABP with the stimuli-responsive 
group in the middle of triblock copolymers are shown. In these systems, the 
stimuli-responsive group is found in the core of the micelle and upon cleavage the 
resulting block copolymer retains amphiphilicity.
[36]
 Such a process enables a 
change in the size of the monocleavable micelles. There has been a limited 
number of reports that describe methods to synthesize these monocleavable 






 or reversible 
addition-fragementation chain transfer (RAFT).
[39]
 As a result, in this thesis 





Figure 1.5. Approaches to synthesis of disulfide-containing block copolymers 




1.5 Biocompatible polylactide and their nanomaterials 
1.5.1 Polylactide and its challenges in biomedical applications 
The biomaterial of choice for my research is poly(D,L-lactide) (PLA) 
(Figure 1.6). PLA is a class of hydroxyalkanoic acid-based hydrophobic aliphatic 
polyesters, along with polycaprolactone (PCL) and polyglycolic acid.
[41]
 PLA 
shows tunable mechanical properties
[42]
, biodegradability through hydrolysis of 





 PLA has been FDA-approved for its clinical use. Because of 
these advantageous properties, PLA has found numerous applications, namely in 
drug delivery,
[45]
 as tissue scaffolds,
[46]

























Figure 1.6. D,L-polylactide. 
Although PLA has numerous advantages rendering it a promising platform 
as a material of choice for the development of biomedical applications, there are 
two main limitations that need to be addressed to promote commercial value of 
PLA-based drug delivery systems.
[48]
 The first limitation involves its inherent 
hydrophobicity.
[49]
 PLA is hydrophobic and therefore if injected inside the 
bloodstream, this aqueous environment will cause its aggregation and 
precipitation of the polymer. These aggregates can be recognized as foreign 
materials and be cleared by the reticulo-endothelial system (RES); a component 
of the immune system consisting of phagocytic cells. To circumvent this 
limitation two strategies have been proposed. One strategy is to functionalize PLA 
with a hydrophilic polymer in a copolymer architecture which allows the 
preparation of self-assembled nanoparticles with the hydrophobic PLA as a core 
and reservoir and the hydrophilic polymer as a corona surrounding the PLA core 
and providing colloidal stability.
[48]
 The other approach involves the 
copolymerization of PLA with hydrophilic monomers to form microparticles that 
have the ability to encapsulate the therapeutic molecules of choice, while still 
rendering PLA less hydrophobic.
[50]
 
The other limitation is the slow biodegradation of PLA. Although PLA is 
biodegradable via hydrolysis of the ester bonds or enzymatic cleavage using 
Proteinase K, the degradation process is slow. Indeed, the hydrolysis of the ester 
bonds occurs via a bulk erosion mechanism, whereas PLA is hydrophobic and 





 Due to this slow degradation, PLA-based drug 
delivery systems are characterized by a slow and uncontrolled delivery of the 
loaded therapeutics.
[51]
 A promising solution to improve the release is to introduce 
SRD platform in the design of PLA-based drug delivery systems, which has been 
proposed by Prof. Oh's research group. With promising disulfide-thiol chemistry, 
our group has continued to put significant efforts to develop a variety of disulfide 
containing PLA-based ABPs. Examples include sheddable micelles and fibres 
having disulfides located at block junction of diblock copolymers,
[33b, 52]
 as well 
as inter-layered crosslinked micelles having disulfide linkages positioned at dual 
locations of a triblock copolymer.
[53]
 A promising and interesting system is the 
monocleavable micelle having disulfide linkages in the middle of PLA-based 
triblock copolymers. Because few reports have been directed at the study of this 
system, the disulfide-labeled monocleavable triblock copolymer was studied in 
order to gain a greater insight on the structure-property relationship between this 
morphological variance and its impact on the stimuli-responsive degradation. The 
prospect held by this architecture for efficient drug delivery is outlined in the 
belief that retaining amphiphilicity post-drug release allows for a safe removal of 
the empty delivery agents. Numerous drug delivery methods either result in the 
formation of hydrophobic aggregates following stimuli-responsive degradation or 
rely on the dissolution of the copolymer chains. Potential toxicity issues may arise 
under these circumstances which may be averted by exploiting this 
monocleavable system.  
1.5.2 Literature related monocleavable micelles 
This section is to briefly summarize strategies to synthesize 
monocleavable micelles reported in the literature. In one example, a thiol-alkyne 
click reaction was used to prepare mPolycaprolactone-b-Polyehtylene oxide 
(mPCL-b-PEO) multi-armed biodegradable block copolymers with the disulfide 
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bond in the core.
[37]
 The srategy was based on the click reaction between an 
alkyne-terminated, disulfide-labeled linker and a thiol-terminated PEG-b-PCL 
diblock copolymer which gave rise to monocleavable ABP with the disulfide 
bond in the core. These ABPs assembled into bioreducible micelles that presented 
thiol-triggered drug release properties. In presence of thiol-reducing agents, the 
micelles showed a reduction in size, without alterations in their morphology, and 
an improvement of drug release. In another strategy, a dual stimuli-sensitive star 
polypeptide was synthesized with a disulfide bond in the middle of the star.
[38]
 
The four branched star-liked structure was prepared using a disulfide-bond-cored 
tetra(amine) as an initiator for the ring-opening polymerization (ROP) of 
diethylene glycol-L-glutamate N-carboxyanhydride. The resulting disulfide-
labeled ABP were able to form micelles in aqueous environment and showed 
stimuli-responsive drug release properties. Moreover, a different strategy 
employed a combination of reversible-addition fragmentation chain transfer 
(RAFT) and ROP to prepare star-like terpolymers.
[39a]
 In this example, the 
strategy was based on first using a disulfide-labeled RAFT agent for the 
sequential polymerization of vinyl-benzyl terminated polyethylene gycol (St-
PEG) followed by N-(2-hydroxyethyl) maleimide (HEMI). Then, the terminal 
hydroxyl ends of HEMI were used as initiators for the ROP synthesis of PCL. The 
resulting synthetic strategy gave rise to a mid-disulfide-linked comblike 
copolymer of the form S-CP(PEG-alt-PCL) which were then studied for their 
potential as drug delivery systems.  
 In light of all the previously discussed advantages confered by the 
combination of ABP and SRD strategies in the design of drug delivery systems, 
the proof of concept based on these systems has made its mark. Indeed, a great 
deal of effort has been directed towards understanding the necessary components 
of a successful drug delivery system and the SRD platform is the missing link. In 
 19 
 
retrospect, albeit not a challenge to the central tenet brought about by Paul 
Erlich`s magic bullet but merely a humble observation of the current situation, 
little progress has been made from the benchtop to a prescribed ABP-based drug. 
This observation stems from the tremendous amount of literature that deal on 
ABP-based drug delivery system, but the scarce amount of prescribed drugs that 
utilize this concept. Part of the answer to this observation may be found in the 
inadequate understanding between the structure-property relationship between 
morphological variance and stimuli-responsive degradation. A greater 
understanding would enable the optimization of the design of these delivery 
systems. Moreover, another deficiency in our progress is the development of 
synthetic methods that allow a reproducible and cheap synthesis of these ABP-
based systems to render the commecialization of these products feasible and 
attainable. The topic of my research has been directed toward the development of 
different synthetic strategies to prepare PLA-based disulfide-labeled 
monocleavable triblock ABP. To the best of my knowledge, there are no reports 
that propose a synthetic strategy of disulfide-labeled linear triblock copolymers 
which use PLA as the hydrophobic block. Moreover, the impact of this 
morphology on the SRD and corollary drug release was studied. Different 
synthetic strategies were proposed in order to augment the possible combination 
of hydrophobic and hydrophilic polymers that can be used to form the 
monocleavable triblock ABP. Finally, their potential as drug delivery systems 
were studied to give a greater insight of the use of this morphology and the use of 
the disulfide bond in drug delivery applications.   
1.6 Scope of the thesis 
 In this thesis, the research conducted and results obtained are described in 
three chapters. In chapter 2, the synthesis and characterization of PLA-based 
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ABPs and their self-assembled nanostructures are presented along with the 
relevant background information.  
 In chapter 3, the novel synthesis of well-defined reduction-responsive 
degradable PLA-based micelles having disulfide linkages in the middle of triblock 
copolymers is reported. The proposed ABP was synthesized by a combination of 
a facile controlled polymerization technique, atom transfer radical polymerization 
(ATRP) and ring-opening polymerization (ROP). The central disulfide linkages 
were cleaved in response to thiols, enhancing release of encapsulated anticancer 
drugs.  
 In chapter 4, another synthetic method for the preparation of 
monocleavable micelles is presented. The approach combines the use of ROP and 
a facile coupling reaction to prepare an ABP composed of biocompatible and 
FDA-approved polymers, polyethylene oxide (PEO) and PLA. In addition, the 
proposed PEO-b-(PLA-SS-PLA)-b-PEO triblock copolymer was evaluated for its 
prospective drug delivery applications. Indeed, PEO has been found to be the 
ideal hydrophilic block in the design of drug delivery systems exhibiting 
enhanced colloidal stability and preventing non-specific protein interactions. 
Further, thiol-triggered release enabled the enhanced drug release in response to 
glutathione, a cellular trigger.  








Methodology: Synthesis and 
Characterization 
2.1. Brief description 
 This chapter describes the methodology used for the synthesis and 
characterization of the monocleavable triblock copolymers and their self-
assembly driven aggregation into micelles, as well as the techniques used to 
determine their biological and biomedical applications. Their detailed 
experimental procedure are described in chapter 3 & 4 (Experimental).  
2.2 Synthesis and characterization of triblock copolymers 
2.2.1 ROP for the synthesis of PLA 
 In order to be used in biomedical applications, polymers and copolymers 
need to have a small population distribution. Hence, a precise and stringent 
control on their polymerization is necessary. To obtain an amphiphilic triblock 
copolymer, PLA was used as the hydrophobic block. There have been various 
methods that have been developed to synthesize PLA.
[54]
 Most notably, a direct 
polycondensation polymerization of lactic acid in the presence of a catalyst under 
reduced pressure affords PLA.
[54]
 However, this method suffers from certain 
drawbacks in that the polymers obtained have a low molecular weight due to the 
difficulties of removing water from the viscous mixture as it is generated and the 
stereoregularity cannot be controlled during the course of the reaction.
[54]
 Variants 
of this method are azeotropic condensation polymerization that affords polymers 
with large molecular weights, and solid state polymerization that offer a rigorous 
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control over side reactions. Another method that most widely used to synthesize 
PLA is the ring opening polymerization.
[41, 54-55]
 Demonstrated by Carothers et al. 
in 1932, this method offers control of the PLA chemistry and properties, as well 
as their stereoregulation.
[41, 54-55]
 Here, the monomers are the cyclic dimers of 
lactic acid. There exist three types of ROP based on their reaction mechanism: 
anionic, cationic, and coordination-insertion mechanism.
[54]
 In the anionic 
polymerization, a nucleophilic anion attacks the carbonyl carbon and results in the 
cleavage of the carbonyl carbon and the endocyclic oxygen. These 
polymerizations are characterized by racemization, back biting and other side 
reactions due to the presence of highly active catalysts at high temperatures 
(Figure 2.1).
[56]
 In the cationic polymerization, an exocyclic oxygen of the lactide 
monomer is either alkylated or protonated causing the resulting oxygen to become 
positively charged, followed by subsequent nucleophilic attacks by the acidic 




Figure 2.1. Scheme for the (a) anionic ROP of LA and (b) cationic ROP of LA in 
the presence of methyl trifluoromethanesulfonate (MeOTf).
[55]





Similarly, due to the high temperature requirements, racemization is often 
encountered. Finally, the ROP method that was used in this research is the 
coordination-insertion mechanism which is the most widely used for the synthesis 
of high molecular weight PLA with well-defined molecular weight and 
stereoregulation. As depicted in Figure 2.2, the first step of the polymerization is 
the coordination of oxygen of the initiator with the metal atom found on the 
catalyst.
[55, 57]
 This coordination increases the nucleophilicity of the oxygen. Then, 
the exocyclic oxygen of lactide is coordinated with the metal atom displacing the 
alkoxide initiator which then attacks the lactide at the carbonyl carbon followed 
by ring opening. This two step-attack and ring opening result in the insertion of a 
monomer into the OH bond of the initiator. These steps are repeated until all 
monomers are exhausted. A great deal of catalysts have been studied for the ring 
opening polymerization of lactide, however in this research the Tin(II) 2-
ethylhexanoate (Sn(Oct)2) catalyst has been used because it is soluble in many 




Figure 2.2. Scheme (a) and mechanism (b) for the coordination-insertion ROP of 
LA in the presence of Sn(Oct)2.
[55]
   
2.2.1 ATRP for the synthesis of ABP 
 Another polymerization technique that allows the synthesis of well-
controlled polymers and copolymers with a narrow molecular weight distribution 
and various architectures is ATRP. Independently discovered by both Mitsuo 
Sawamoto
[58]
 and by Jin-Shan Wang and Krzysztof Matyjaszewski
[59]
 in 1995, 
this technique falls in the category of controlled radical polymerization. This 





Due to the presence of the radical species as propagating centers, this type of 
polymerization is limited to monomers that contain substituent groups that can 
stabilize the propagating radicals, such as styrenes, acrylates, acrylamides, and 
acrylonitrile.
[60]
 ATRP finds various applications, notably in the synthesis of ABP 
for biomedical applications due to its numerous advantages: 1) synthesis of well-
controlled polymers with predetermined molecular weights and low 
polydispersity; 2) synthesis of polymers with various topologies; 3) synthesis of 
copolymers with different compositions; 4) synthesis of polymers with different 
terminal functional groups, which can be used, for example, to couple ligands for 
receptor-mediated endocytosis in specific cells. 
 As depicted in Figure 2.3, ATRP relies on equilibrium between actively 
propagating chains and dormant chains. In ATRP, a halogen atom undergoes a 
reversible, homolytic halogen transfer from an initiator species to a transition 
metal complex in its lower oxidation state.
[61]
 This activation, characterized by the 
rate constant (kact), generates active radical chains ends. Monomers are 
sequentially added to this radical chain end by which polymer chains grow. This 
propagation is characterized by the rate constant (kp). The propagation ends either 
through reversible deactivation with a rate constant kdeact or by undesired 
irreversible termination reactions with a rate constant kt. By keeping the 
concentration of dormant species higher than the concentration of active species, 
the amount of irreversible termination reactions is diminished (kdeact >> kact). 
Moreover, kact > kp such that all chains are propagating at the same time aiding in 




Figure 2.3. Mechanism for ATRP polymerization.
[62]
  
2.2.2 Copolymer characterization: Gel permeation chromatography (GPC) 
 Polymers are characterized by population distributions. In order to better 
depict this population distribution and understand their properties polymers are 
reported according to their number-average molecular weight (Mn), weight-
average molecular weigth (Mw), and polydispersity index (PDI). The Mn is the 
number-average molecular mass of the polymers present in the sample according 
to the number fraction of polymer chains and is defined by: Mn = (ΣNiMi)/(ΣNi), 
where Ni is the number of polymer chains and Mi is the weight or weight class for 
a polymer. On the other hand, the Mw is the weight-average molecular mass of the 
polymers present in the sample according to the weight fraction of these polymer 
chains and is defined by: Mw = (ΣNiMi
2)/(ΣNiMi). Finally, the PDI is a measure of 
the dispersity of the population such that a PDI of 1 indicates a monodisperse 
population. The value for the PDI may be obtained from the following: PDI = 
Mw/Mn.  
 Gel permeation chromatography (GPC) is a convenient method to 
determine relative (not absolute) molecular weight data. GPC separates polymer 
chains with respect to their hydrodynamic volumes, which itself depends on the 
molecular weight and molecular conformation of the polymer in solution. In this 
case, a polymer solution is injected inside the instrument where an eluent (mobile 
phase and good solvent for the polymer) carries the polymer through columns 







P = Polymer chain 
X = Halogen atom (Br or Cl) 
L = Ligand 
Mt = Transition metal 
kact = Activation rate constant 
kdeact = Deactivation rate constant 
kp = Propagation rate constant 
kt = Termination rate constant 
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filled with porous beads. At the end of the column, a detector measures the 
refractive index monitors the concentration by weight of polymer solution that 
elutes from that column. Polymer chains are separated based on their 
hydrodynamic volume by interaction with the porous beads. Short polymer chains 
may enter these pores and spend more time to travel across the column and reach 
the detector, whereas long polymer chains with a large volume are too big to 
interact with these pores and elute first. The time point at which these polymers 
elute is referred to as either the retention time or volume. By constructing a 
calibration curve with the known calibration standards of pre-determined 
molecular weight, the relative molecular weight of the polymer is determined. 
The typical calibration standards available include polystyrene (PSt) and 
poly(methyl methacrylate) (PMMA).  
 







2.3 Aqueous micellization and characterization 
2.3.1 Preparation of micellar aggregates 
 As discussed in section 1.3.5, various techniques for the preparation of 
micelles have been developed and allow nanoparticles of different sizes to be 
prepared using polymers with different properties.
[22]
 The two methods that were 
mainly used in this research are the emulsification-solvent evaporation technique 
and the dialysis technique. In the solvent evaporation technique the ABP is 
dissolved in a volatile solvent, here THF, and mixed with deionized water. 
Formation of the NP is achieved as the solvent is evaporated and the ABP comes 
together in a thermodynamically driven aggregation to minimize contact of the 
hydrophobic block with water.
[49c]
 The parameters affecting the NP formation are 
the evaporation temperature and pressure.
[13]
 In the second method, the ABP is 
dissolved in a water-miscible solvent, here N,N-dimethylformamide (DMF), and 
transferred to a semi-permeable membrane. This solution is dialyzed against 
water with the dialysis bag preventing the micelles from diffusing out of the 




2.3.2 Determination of critical micellar concentration (CMC) 
 As discussed in section 1.3.4, the CMC is the concentration of ABP above 
which micellar particles form in a thermodynamically driven self-assembly.
[15]
 
There exist different methods based on physical or chemical concepts to 
determine the CMC of an ABP-based micelle. Typical methods based on physical 
concepts include tensiometry, which measures changes in surface tension of a 
polymer solution as the concentration of polymer is increased, or electrical 
conductivity, which measures increases of electrical conductivity as ionically 





 On the other hand, chemically-based methods have been developed which 




 In this research, 
fluorescence spectroscopy using NR as a probe was used to determine the CMC 
of the ABP. NR is a solvatochromic probe that undergoes a shift in its emission 
spectrum based on the environment in which it is found.
[65]
 Typically, NR 
undergoes a twisted-intramolecular chain transfer upon excitation where ground 
state electrons are excited to higher energy levels.
[67]
 Then, these electrons will 
populate degenerate excited states based on the environment in which NR is 
found. These excited states are high in energy and can be stabilized in a polar 
environment such that depending on the polarity of the environment in which NR 
is found, different excited states with different energies are populated.
[68]
 These 
different excited states will then emit fluorescence energy which can be measured 
with the help of a fluorimeter. By measuring the changes in fluorescence intensity 
at a specific emission wavelength the environment of the NR probe can be 
followed.
[68]
 At this wavelength, when NR is in an aqueous environment, the 
fluorescence intensity is quenched due to its poor water solubility. However, once 
NR is encapsulated in the hydrophobic core of the micelle, the fluorescence 
intensity at this wavelength increases with respect to concentration.
[68]
 Therefore, 
by preparing different polymer solutions at different concentrations and allowing 
them to form micelles using the emulsification-solvent evaporation technique in 
the presence of NR, the CMC can be obtained by observing the concentration of 





Figure 2.5. Twisted intramolecular chain transfer leading to NR excited state. 
2.3.3 Size and morphology characterization 
 Dynamic light scattering (DLS) is a common technique that allows 
analyzing the size of colloidal dispersions. For the DLS measurements, incident 
light is directed to the cuvette containing colloidal dispersions when colliding 
with particles. The intensity of the scattered light is measured using appropriate 
optical arrangements. Note that the light scattering intensity of particles is 
inversely proportional to the size of the molecules. The integrated intensities of 
the particles in the dispersion are fitted to a valid mathematical model. From this 
model, the translational diffusion coefficient (D) is obtained and used to calculate 
the hydrodynamic diameter (d (H)) of the particles using the Stokes-Einstein 
equation.    
Stokes-Einstein equation: 
d(H) = kT / 3πηD 
where, k is the Boltzmann's constant, T is the absolute temperature of 
measurement, and η is the viscosity of the medium.   
 Imaging techniques such as transmission electron microscopy (TEM) are 
used to investigate particle morphologies. For TEM, a specimen is loaded onto a 




electrons interact with the sample on the specimen or pass through and the image 
that is observed is the electrons that have passed. Typically, the specimen used for 




















New design of thiol-responsive PLA-based 




A new design to synthesize reduction-responsive degradable PLA-based 
micelles having a disulfide linkage in the middle of triblock copolymers (ssABP-
1) is presented in this chapter. They were synthesized by a new method that 
centers on the use of a disulfide-labeled diol as an initiator for ring opening 
polymerization, followed by controlled/living radical polymerization. These well-
controlled copolymers with monomodal and narrow molecular weight distribution 
(Mw/Mn < 1.15) self-assembled, through aqueous micellization, to form micellar 
aggregates with disulfide-containing PLA cores, which is not toxic to cells. 
Central disulfide linkages were cleaved in response to thiols; such thiol-triggered 
degradation enhanced the release of encapsulated anticancer drugs.  
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 FDA-approved for 
clinical use, and biodegradable through enzymatic reactions and hydrolysis in 
physiological conditions.
[43]
 These unique properties have recently facilitated its 





 and nanocrystal-embedded imaging platforms.
[47]
 Toward the 
successful biological applications of PLA and its copolymers, a challenge 
involves their hydrophobicity.
[49a, 49b]
 In general, hydrophobic PLA copolymers 
are modified with hydrophilic polymers
[48]
 or copolymerized with hydrophilic 
monomers.
[50]
 This approach has been facilitated by preparing PLA-containing 
amphiphilic block copolymers typically with hydrophilic polymethacrylates.
[48]
 
The resulting PLA-based block copolymers form self-assembled micellar 
aggregates in aqueous solutions, consisting of hydrophobic PLA cores surrounded 
with hydrophilic coronas. Another critical challenge to be addressed is the slow 
degradation of PLA and thus slow and uncontrolled release of encapsulated 
drugs.
[51]
 Such slow release is attributed to delayed diffusion through the 
hydrophobic PLA core due to both hydrophobic interactions as well as the slow 
hydrolysis of the ester linkages of the PLA backbones. Several approaches 
including hydrolytic degradation at low pH
[69]
 and mixed micelles with pH-
responsive block copolymers
[70]
 have been proposed; however, strategies toward a 
rapid and controlled degradation and release remain limited. 
Stimuli-responsive degradation (SRD) is a desired property in constructing 
multifunctional nanocarriers.
[25]
 SRD in response to external triggers enables not 
only enhancing the release of encapsulated biomolecules
[28, 32, 71]
 but also tuning 
the morphologies of self-assembled nanostructures.
[72]
 In general, stimuli-
responsive cleavable linkages are incorporated into block copolymer micelles. 
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These linkages are then cleaved when they are triggered by low pH, light, or 
ultrasound, as well as reductive, oxidative, or enzymatic reactions, causing the 
nanomaterials to dissociate. Disulfide-thiol degradation is a promising SRD 
platform because disulfide linkages are cleaved to the corresponding thiols in 
response to reductive reactions.
[29]
 Moreover, glutathione (GSH, a tripeptide 
containing cysteine and a reducing agent for disulfide linkages) is found at a 
higher concentration in intracellular environments than in extracellular 
environments,
[30]
 and even at elevated levels in cancer cells.
[31a, 31c]
 These features 
promote the use of the degradation platform for the development of self-




 In this chapter, a new method for the preparation of thiol-responsive 
degradable PLA-based triblock copolymer micelles exhibiting enhanced drug 
release will be presented. These micelles consist of well-controlled, 
monocleavable PLA-based amphiphilic triblock copolymers having a single 
central disulfide linkage in the middle of the hydrophobic block (called ssABP-1). 
These thiol-responsive block copolymers were synthesized by a combined method 
of ROP and ATRP; the method initiates the use of a disulfide-labeled diol as a 
ROP initiator. Then, they were characterized for aqueous micellization and thiol-
responsive degradation. Well-controlled ssABP-1 self-assembles to form aqueous 
micellar aggregates. In response to thiols, the central single disulfide linkage in 
micellar core is cleaved, resulting in degradation of ssABP-1 to HS-ABP that 
retains amphiphilic character, thus causing micellar aggregates to change their 






3.2 Experimental  
3.2.1 Instrumentation and analyses 
1
H-NMR spectra were recorded using a 500 MHz Varian spectrometer. 
The CDCl3 singlet at 7.27 ppm was selected as the reference standard. Spectral 
features are tabulated in the following order: chemical shift (ppm); multiplicity (s 
- singlet, d - doublet, t – triplet, m - complex multiplet); number of protons; 
position of protons. Molecular weight and molecular weight distribution were 
determined by gel permeation chromatography (GPC) with a Viscotek VE1122 
pump and a refractive index (RI) detector. Two PolyAnalytik columns (PAS-
103L, 106L, designed to determine molecular weight up to 2,000,000 g/mol) were 
used with THF as an eluent at 30 C and at a flow rate of 1 mL/min. Linear 
polystyrene standards were used for calibration. Aliquots of polymer samples 
were dissolved in THF and the clear solutions were filtered using a 0.25 m PTFE 
filter to remove any THF-insoluble species. A drop of anisole was added as a flow 
rate marker. Conversion for ATRP of OEOMA was also determined using GPC 
by following the decrease of macromonomer (OEOMA) peak area relative to the 
increase of polymer peak area. The sizes of micelles in hydrodynamic diameters 
by volume were measured by dynamic light scattering (DLS) at a fixed scattering 
angle of 173° at 25 °C with a Malvern Instruments Nano S ZEN1600 equipped 
with a 633 nm He-Ne gas laser. All micellar dispersions without dilution were 
filtered by 0.45 m PES filter to remove large aggregates. Fluorescence spectra 
were recorded on Varian Cary Eclipse Fluorescence spectrometer using a 1-cm 





3.2.2 Thermal analysis 
Thermal properties including glass transition temperature (Tg) of ss(PLA-Br)2 and 
ssABP-1 were measured with a TA Instruments DSC Q10 differential scanning 
calorimeter over a temperature range of -70 to 200 C at a heating rate of 10 
C/min (cycles: cool to -70 C, heat up to 200 C (1st  run 1), cool to -70 C, heat 
up to 200 C (2nd run), and cool to 25 C). The Tg values were determined from 
the 2
nd
 heating run. 
3.2.3 Materials  
2-Hydroxyethyl disulfide (ssDOH), -bromoisobutyryl bromide (Br-
iBuBr), triethylamine (Et3N), 3,6-dimethyl-1,4-dioxane-2,5-dione (DL-lactide, 
LA), tin(II) 2-ethylhexanoate (Sn(Oct)2, 95%), N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDETA, >98%), Nile Red (NR), potassium 
phosphate monobasic (KH2PO4), methanol (MeOH), and copper(I) bromide 
(CuBr, >99.99%) from Aldrich, and DL-dithiothreitol (DTT, 99%) from Acros 
Organics were purchased and used as received. Oligo(ethylene glycol) 
monomethyl ether methacrylate (OEOMA) with M = 475 g/mol and pendent EO 
units DP  7 from Aldrich was purified by passing it through a column filled with 
basic alumina to remove the inhibitors.  
3.2.4 Synthesis of ss(PLA-OH)2 by ROP  
ROP of LA was conducted in the presence of ssDOH difunctional initiator 
in toluene at 120 C. The detailed procedure is as follows; ssDOH (45.9 mg, 0.3 
mmol), LA (3.0 g, 20.8 mmol), Sn(Oct)2 (6.0 mg, 0.02 mmol), and toluene (2 mL) 
were added to a 10 mL Schlenk flask. The resulting mixture was deoxygenated by 
four freeze-pump-thaw cycles. The reaction flask was filled with nitrogen, 
thawed, and then immersed in an oil bath preheated at 120 °C to start the 
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polymerization. After 2.5 hrs, the polymerization was stopped and cooled to room 
temperature. The resulting homopolymers were precipitated from MeOH 
containing a trace amount of HCl (note that LA is soluble in MeOH). They were 
then isolated by vacuum filtration and further dried in a vacuum oven at 50 C 
overnight, resulting in a white solid.  
3.2.5 Esterification to ss(PLA-Br)2  
The purified, dried ss(PLA-OH)2 homopolymers were brominated by 
reacting with Br-iBuBr (10 mole equivalents to hydroxyl groups of ss(PLA-OH)2) 
in the presence of Et3N. For the detailed procedure, ss(PLA-OH)2 (4.0 g, 0.6 
mmol) and Et3N (0.6 g, 6.0 mmol) were dissolved in tetrahydrofuran (THF, 50 
mL). The resulting mixture was purged with N2 for 30 min. Br-iBuBr (1.4 g, 6.0 
mmol) was added drop-wise for 15 min in an ice bath at 0 C and then kept at 
room temperature for 12 hrs. The formed solids (HCl:Et3N adducts) were 
removed by a vacuum filtration and then purified by precipitation from MeOH to 
remove excess Et3N and Br-iBuBr, which is soluble in MeOH, for the former, or 
react with MeOH, for the latter. The precipitates were collected and dried in a 
vacuum oven at room temperature for 12 hrs. The extent of esterification was 
determined by 
1
H-NMR in CDCl3.  
3.2.6 Synthesis of ssABP-1 by ATRP  
The standard procedure for normal ATRP of OEOMA was catalyzed with 
CuBr/PMDETA in the presence of ss(PLA-Br)2 macro-initiator in THF at 47 C. 
The dried, purified ss(PLA-Br)2 (1.0 g, 0.15 mmol), OEOMA (1.4 g, 3.0 mmol), 
PMDETA (31.5 L, 0.15 mmol), and THF (3 mL) were mixed in a 10 mL 
Schlenk flask. The resulting mixture was deoxygenated by four freeze-pump-thaw 
cycles. The reaction flask was filled with nitrogen and CuBr (21.6 mg, 0.15 
mmol) was then added to the frozen solution. The flask was sealed, purged with 
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vacuum and backfilled with nitrogen once. The mixture was thawed and the flask 
was then immersed in an oil bath preheated to 47 °C to start the polymerization. 
Aliquots were withdrawn at different time intervals during the polymerization to 
monitor conversion and molecular weight by GPC. The polymerization was 
stopped at 2 hrs by exposing the reaction mixture to air.  
The resulting polymers were purified by the removal of residual copper 
species and unreacted monomers as follows; As-prepared green polymer solutions 
(ca. 5.5 g) were added drop-wise into hexane (350 mL) under stirring. The green 
precipitated polymers were passed through a column filled with basic aluminum 
oxide with THF as an eluent to remove copper species three times. Solvent was 
removed by rotary evaporation and residual solvent was further removed using a 
vacuum oven at room temperature overnight, yielding ssABP-1. The theoretical 
molecular weights over conversion were predicted using the equation: 
[OEOMA]0/[ss(PLA-Br)2]0 x conversion x MW (OEOMA = 475 g/mol) + MW 
(ss(PLA-Br)2 determined by 
1
H NMR). 
3.2.7 Aqueous micellization  
An aqueous KH2PO4 buffer solution at pH = 7 was added drop-wise into 
an organic mixture of the purified, dried polymers and THF. The resulting 
dispersion was stirred for >12 hrs to remove THF through evaporation, yielding 
colloidally stable micellar dispersions at various concentrations. For the 
preparation micelles at 0.1 mg/mL, ssABP-1 or HS-ABP (10 mg), THF (3 mL), 
and water (100 mL) were used. 
3.2.8 Determination of critical micellar concentration (CMC) using a NR 
probe  
A stock solution of NR in THF at 1 mg/mL and a stock solution of ssABP-
1 in THF at 1 mg/mL were prepared. Water (10 mL) was then added drop-wise 
 40 
 
into mixtures consisting of the same amount of the stock solution of NR (0.5 mL, 
0.5 mg NR) and various amounts of the stock solution of ssABP-1. The resulting 
dispersions were stirred for 12 hrs to remove THF, and were then subjected to 
filtration using 0.45µm PES filters to remove excess NR. A series of NR-loaded 
micelles at various concentrations of ssABP-1 ranging from 10
-6
 to 0.1 mg/mL 
were formed. From their fluorescence spectra recorded with ex = 480 nm, the 
fluorescence intensity at maximum λem = 620 nm was recorded. 
3.2.9 Reductive degradation of ss(PLA-OH)2 and ssABP-1 in DMF  
For the degradation of ss(PLA-OH)2 precursors in the presence of DTT, a 
stock solution of DTT in DMF at 100 mg/mL was prepared. ss(PLA-OH)2 (100 
mg, 10.7 mol) was mixed with the stock solution of DTT (82.3 L, 53.5 mol) 
and DMF (5 mL) under stirring. For ssABP-1 in the presence of DTT, ssABP-1 
(50 mg, 3.9 mol) was mixed with the stock solution of DTT (100 mg/mL, 30.1 
L, 19.5 mol,) and DMF (5 mL) under stirring. Aliquots of the sample were 
taken periodically for GPC analysis. For 
1
H-NMR analysis in CDCl3, DMF was 
evaporated using a rotary evaporator. 
Upon the cleavage of disulfides in ss(PLA-OH)2 in response to DTT, a 
NMR peak at 2.9 ppm corresponding to methylene protons adjacent to disuflide 
disappeared and a new peak at 2.75 ppm appeared. This peak can be assigned to 
methylene protons adjacent to terminal thiol (-SH). In addition, a multiple peak at 
4.3-4.5 ppm was split into two distinct peaks: one corresponding to methine 
protons at the end of chains of PLA block and the other corresponding to 






3.2.10 Thiol-responsive degradation of aqueous micelles  
A micellar dispersion of ssABP-1 at 0.1 mg/mL (4 mL, 0.4 mg ssABP-1) 
was mixed with a stock solution of DTT in water (1 mg/mL, 4.8 L, 0.03 mol). 
DLS was used to measure micellar sizes and size distributions. For GPC 
measurements, water was evaporated using rotary evaporator and the dried 
polymer was dissolved in THF. 
3.2.11 Encapsulation of Dox          
 A Dox-loaded micellar dispersion was prepared as follows; an aliquot of 
ssABP-1 (20 mg), Dox (2.0 mg, 3.45 μmol), and triethylamine (0.47 mg, 4.69 
μmol), and DMF (1.9 g) were mixed with water (6 mL) for 2 hrs. The resulting 
dispersion was dialyzed using a dialysis tubing with MWCO = 3,500 g/mol over 
water for 24 hrs to remove free Dox. To determine the loading level of Dox by 
UV/Vis spectroscopy, an aliquot of Dox-loaded micellar dispersion (1 mL) was 
mixed with DMF (5 mL) to form a clear solution of DMF/water = 5/1 v/v. The 
UV/Vis spectrum was recorded and the loading level of DOX was calculated by 
the weight ratio of loaded DOX to dried polymers. 
3.2.12 Release of Dox from Dox-loaded micelles upon thiol-responsive 
degradation          
Aliquots of the Dox-loaded micellar dispersion at 1.1 mg/mL (5 mL) was 
transferred into dialysis tubing and immersed in PBS containing 10 mM GSH at 
pH = 7.4 (60 mL) as well as PBS (pH = 7.4) as a control; to note the pH was 
adjusted to 7.4 for the 10mM GSH solution by adding 0.1 M NaOH. The 
fluorescence spectra of the outer water were measured over 27 hrs. To quantify 
the % Dox released from micelles, Dox (0.066 mg, equivalent to Dox 
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encapsulated in 5 mL of Dox-loaded micelles) and Et3N (0.03 mg, 3 mol 
equivalents) were dissolved in PBS (60 mL) to measure the fluorescence 
spectrum. 
3.3 Results and discussion 
3.3.1 Synthesis of ssABP-1 from a combination of ROP and ATRP 
 The synthetic strategy to prepare well-controlled PLA-based 
monocleavable amphiphilic triblock copolymer based on three synthetic steps 
consists of 1) ROP of LA in the presence of tin octoate (Sn(Oct)2) as a catalyst 
and 2-hydroxyethyl disulfide (SS-DOH) as an initiator to synthesize ss(PLA-
OH)2, 2) esterification of ss(PLA-OH)2 to afford ss(PLA-Br)2  ATRP macro-
initiator, and 3) chain extension of ss(PLA-Br)2 with water-soluble POEOMA by 
ATRP.  
 
Figure 3.1. Synthetic strategy for the preparation of PLA-based monocleavable 
triblock copolymers.  
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 As the first synthetic step, well-controlled ss(PLA-OH)2 was synthesized 
by ROP of LA initiated with ssDOH in the presence of Sn(Oct)2 in toluene at 120 
C (note that D,L-lactide is used in this research). As discussed in section 2.2.1, 
the ROP of cyclic esters such as LA in the presence of Sn(Oct)2 proceeds via 
monomer insertion into tin(II)-oxygen bond of alkoxide active centers.
[55, 57]
 As a 
consequence, the amount of Sn(Oct)2 is an important parameter that influences the 
rate of ROP. In the experiments, the mole ratio of [Sn(Oct)2]0/[ss-DOH]0 = 0.05/1 
was used with [LA]0/[ss-DOH]0 = 70/1. The resulting polymers were purified by 
precipitation from MeOH containing a trace amount of HCl, and then isolated by 
vacuum filtration. For the purified, dried ss(PLA-OH)2, GPC results indicate 
molecular weight Mn = 11,000 g/mol with monomodal and narrow molecular 
weight distribution as low as Mw/Mn = 1.15 (Figure 3.2a). Its 
1
H-NMR spectrum 
exhibits a triplet (d) at 2.9 ppm corresponding to methylene protons adjacent to 
disulfides and a multiplet (b) at 5.1-5.3 ppm corresponding to methine protons in 
PLA blocks (Figure 3.2b). From the integral ratio [(b/2)/(d/2)], the DP of ss(PLA-
OH)2 was determined to be 65, corresponding to theoretically calculated Mn,theo = 
9,400 g/mol. Note that the molecular weight determined by GPC which was 
calibrated with polystyrene standards is larger than the theoretically estimated 
one; the difference is attributed to the different hydrodynamic volume of ss(PLA-
OH)2 from PSt homopolymers in THF. 
Next, well-defined ss(PLA-OH)2 was converted to ss(PLA-Br)2 
functionalized with terminal bromine groups by reacting with Br-iBuBr at 
ambient temperature. 
1
H-NMR results show the disappearance of peaks at 4.3-4.4 
ppm (c) corresponding to terminal methine protons of ss(PLA-OH)2 and the 
appearance of two new peaks at 1.95 ppm (f) corresponding to six methyl protons 
adjacent to bromine. The integral ratio of peaks [(f/6)/(d/2)] suggests >95% 
functionalizaton of ss(PLA-OH)2 with bromines to ss(PLA-Br)2 (Figure 3.2a). 
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The purified ss(PLA-Br)2 was used as a macroiniator for ATRP of OEOMA 
under the following conditions: mole ratio of [OEOMA]0/[ss(PLA-
Br)2]0/[CuBr/PMDETA]0 = 20/1/0.5 in THF at 45 C. The polymerization was 
well-controlled due to the following characteristics: first-order kinetics, linear 
increase of molecular weight with conversion, and narrow molecular weight 
distribution (Figure A.1). After the polymerization was stopped at 2 hrs, the 
resulting triblock copolymers were purified by removal of Cu species and 
unreacted monomers. GPC results show the evolution of GPC trace to high 
molecular weight region with no significant traces of ss(PLA-Br)2 macro-initiator 
remaining and Mn = 15,600 g/mol with Mw/Mn = 1.13 (Figure 3.2b). 
1
H NMR 
analysis by taking the integral ratio of peaks [(g/3)/(b/2)] with the DP of PLA 
block = 65 allows to determine the DP = 13 of the POEOMA blocks (Figure 
3.2a). These results suggest the synthesis of well-controlled ss(PLA32-b-






H-NMR spectra of ss(PLA-OH)2, ss(PLA-Br)2, and ssABP-1 in 
CDCl3 where x denotes a trace of THF (a), GPC traces of ssABP-1 compared with 
ss(PLA-OH)2 precursor (b). 
3.3.2 Aqueous micellization of ssABP-1 
 Due to the amphiphilic nature of the ssABP-1, the triblock copolymers 
were allowed to self-assembe using the solvent-evaporation technique discussed 
in section 2.3.1 to form micellar aggregates consisting of disulfide-labeled PLA 
cores surrounded with POEOMA coronas. First, the CMC was determined using 
fluorescence spectroscopy with a Nile Red (NR) probe.
[27b, 74]
 For the experiment, 
a series of mixtures consisting of the same amount of NR and varying amounts of 
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ssABP-1 ranging from 10
-6 
to 0.1 mg/mL in aqueous solution were prepared by 
the solvent evaporation technique where THF was removed by evaporation and 
free NR by filtration.  Figure 3.3a shows that the fluorescence intensity was 
significantly low and did not change for lower concentrations. However, it 
increased with an increasing concentration of ssABP-1. From two equations 
obtained by fitting each data set to a linear relationship, the CMC of ssABP-1 was 
determined to be 5 g/mL. Then, micelles were prepared using the same solvent-
evaporation technique at a concentration of 0.1 mg/mL and their size was 
characterized by DLS. Results show a monomodal distribution with an average 
diameter of 80 nm (Figure 3.3b). 
 
Figure 3.3. Fluorescence intensity of Nile Red for aqueous mixtures consisting of 
NR with various amounts of ssABP-1 to determine the CMC (a), DLS diagram of 
ssABP-1 micelles at a concentration of 0.1 mg/mL in deionized water (b). 
3.3.3 Reduction-responsive disulfide bond cleavage 
 Thiol-responsive degradation and the concomittant morphological 
variance was investigated for both the polymer chains and micellar systems. In 
the first step, several aspects of the thiol-responsive degradation was examined; 
ss(PLA-OH)2 precursors and ssABP-1  were dissolved homogenesouly in DMF 
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and their degradation was examined. It is reported that the degradation is 
enhanced with an increasing amount of thiols.
[35c, 75]
 For this experiment, an 
aliquot of the purified, dried ss(PLA-OH)2 with DP = 65 was mixed with DTT (5 
mole equivalent to disulfides). 
1
H-NMR results suggest the significant cleavage of 
disulfide linkages in ss(PLA-OH)2, yielding HS-PLA-OH as a cleaved product 
(see 
1
H-NMR spectra of ss(PLA-OH)2 before and after the cleavage of disulfides 
in Figure A.2). GPC traces became bimodal with the occurrence of a new peak in 
low molecular weight region (Figure 3.4a). With an increasing degradation time, 
the new peak corresponding to HS-PLA-OH increased, while the original peak 
corresponding to ss(PLA-OH)2 decreased. Peak analysis results suggest that the 
degradation of ss(PLA-OH)2 upon the cleavage of disulfide linkages increased 
over time, reaching >80% in 8 hrs. Molecular weight also decreased from Mn = 
11,000 g/mol to Mn = 7,000 g/mol. Such decrease is attributed to the cleavage of 
disulfide linkages in response to DTT. In order to examine the effect of chain 
length of ss(PLA-OH)2 on the cleavage rate of disulfide linkages, another sample 
of ss(PLA-OH)2 with DP = 46 was synthesized and then mixed with DTT (5 mole 
equivalent to disulfides) in DMF under similar conditions. GPC results indicate 
that the molecular weight rapidly decreased from Mn = 9,600 g/mol to Mn = 5,000 
g/mol within 2 hrs. These results suggest an enhanced degradation of ss(PLA-
OH)2 with a decreasing chain length. Next, an aliquot of ssABP-1 triblock 
copolymers was mixed with 5 mole equivalent DTT to disulfides in DMF. GPC 
results indicate that its molecular weight decreased from Mn = 15,800 to 9,500 
g/mol over 30 hrs at room temperature (Figure 3.4b). Compared to ss(PLA-OH)2, 
the slow degradation of ssABP-1 is probably attributed to both larger chain length 




Figure 3.4. GPC results for the degradation of ss(PLA-OH)2 (a) and ssABP-1 (b) 
mixed with 5 mole equivalent DTT to disulfides in DMF. 
 In the subsequent step, the thiol-induced degradation of the micelles was 
studied using DLS. Here, a micellar dispersion of ssABP-1 at 0.1 mg/mL was 
mixed with a stock solution of DTT in water and the changes in size were 
followed using DLS. DLS results indicate that their diameter slightly decreased 
from 80 to 74 nm in the presence of DTT after 2 days (Figure 3.5a and b). After 
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water was removed, the degraded polymers had  a Mn = 8,400 g/mol (Figure 
3.5c). These results suggest that the central single disulfide linkage of ssABP-1 in 
the micellar core is cleaved in response to thiols yielding amphiphilic HS-PLA-b-
POEOMA (HS-ABP). For other mono-cleavable micelles of triblock copolymers 
having single disulfide, the significant changes in their sizes due to destabilization 
upon the cleavage of disulfide linkages are reported.
[36a, 37]
 The difference in 
destabilization of mono-cleavable micelles is due to the nature and chain length of 




Figure 3.5. DLS diagram of ssABP-1-based micelles before (a) and 2 days after 
(b) the addition of DTT and GPC traces of ssABP-1 micelles without and with 10 
mM DTT after removal of water (c). 
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3.3.4 Thiol-triggered drug release from Dox-loaded ssABP-1 
 Finally, the thiol-triggered drug release of encapsulated anticancer drugs, 
here doxorubicin (Dox), from Dox-loaded micellar aggregates was investigated. 
Dox-loaded micellar aggregates at 1.1 mg/mL were prepared using a dialysis 
method. Using the absorbance at λmax = 497 nm (Figure A.3) and the pre-
determined extinction coefficient, ε = 12,400 M-1cm-1 in a mixture of DMF/water 
= 5/1 v/v,
[53]
 the loading level of Dox was determined to be 1.2%. To examine the 
release of encapsulated Dox in response to GSH, aliquots of the dispersion was 
placed in a dialysis tubing with MWCO = 3,500 g/mol and was dialyzed over a 
PBS solution of 10 mM GSH. The results were compared with a control (dialysis 
without GSH).  Note that the PBS solutions were adjusted to pH 7.4 with the 
addition of 0.1 M NaOH in order to eliminate concerns about the enhanced 
degradation of PLA in acidic pH. The reductive release of Dox from micelles was 
followed using fluorescence spectroscopy. The fluorescence intensity (FI) of Dox 
measured at max = 590 nm, which corresponds to Dox released from Dox-loaded 
micelles, was recorded in the outer solution at given time intervals. Figure A.4 
shows the evolution of fluorescence spectra of outer water (λex = 470 nm) over 
time and % Dox release over time is constructed in Figure 3.6. As can be seen, in 
the presence of 10 mM GSH, the release of Dox was enhanced, compared to 





Figure 3.6. % release profiles of Dox from Dox-loaded micelles in the absence 
(control) and presence of 10 mM GSH in PBS solution adjusted to pH = 7.4. 
3.4 Conclusion 
 New thiol-responsive degradable PLA-based micelles having disulfide 
linkages in the middle of triblock copolymers (ssABP-1) were prepared by a 
combination of ROP in the presence of a disulfide-labeled diol as an initiator and 
ATRP. GPC and NMR results suggest that both polymerizations proceeded in a 
living manner, allowing for the synthesis of well-defined ss(PLA-OH)2 and 
ssABP-1 with monomodal and narrow molecular weight distribution with Mw/Mn 
< 1.15. Aqueous micellization of these ssABP-1 formed self-assembled micellar 
aggregates with disulfide-containing PLA cores. Because of the presence of 
central disulfides, these polymers were degraded in response to thiols upon the 
cleavage of the disulfide linkage. Such thiol-triggered degradation resulted in 
enhanced release of encapsulated anticancer drug to some extent. 





















Alternative method to synthesize reduction-





A new approach utilizing a combination of ring-opening polymerization 
and facile coupling reactions is explored to synthesize a reduction-responsive 
triblock copolymer comprising biocompatible PLA block and poly(ethylene 



























copolymer self-assembles to form colloidally-stable mono-cleavable micelles 
having single disulfides in hydrophobic PLA cores surrounded with PEO coronas 
in aqueous solution. The reductive cleavage of the core disulfides results in 
changes in micellar sizes, depending on the size and nature of reducing agents. 
The size increases in the presence of glutathione (a cellular reducing agent), 
which enhances the release of encapsulated anticancer drugs in vitro. For 
biological prespectives, the ssABP-2 micelles having hydrophilic PEO corona 
exhibit enhanced colloidal stability with no significant non-specific interactions 
with proteins. 
This chapter contains information that was published in Colloids and 
surfaces B: Biointerfaces, 2014, In press, DOI: 10.1016/j.colsurfb.2014.08.002 
















 Well-defined block copolymers exhibiting stimuli-responsive degradation 
(SRD) have attracted significant attention in constructing novel nanomaterials;
[28, 
76]









 and self-assembled micelles.
[32, 
81]
 These SRD block copolymers are generally designed to have dynamic covalent 
bonds (i.e. cleavable linkages), which are later cleaved in response to external 
stimuli. The reduction-responsive disulfide linkages are of particular interest. 
Disulfides are cleaved to the corresponding thiols in the presence of a thiol 
reducing agent.  
A number of disulfide-containing block copolymers and their self-
assembled nanostructures have been developed.
[73a, 82]
 These block copolymers 
are designed with varying numbers of disulfides positioned in single locations, 
including at block junctions
[33b, 33e, 33i, 33j, 35c]
 and as crosslinks
[83]
 as well as in 
pendant chains
[34a, 34c-e]
 and main chains.
[35a, 35c, 35d, 84]
 An interesting system 
contains a disulfide linkage in the center of a triblock copolymer (i.e. AB-SS-BA, 
A and B denoted as a block) which self-assembles to form monocleavable 
micelles having disulfide linkages in the hydrophobic cores.
[85]
 Upon cleavage of 
the disulfide linkages in response to reductive reactions, the cleaved copolymers 
with shorter chain lengths remain amphiphilic (i.e. HS-BA) in micellar forms. 
Such a process produces a change in size and morphology in the monocleavable 
micelles. However, a limited number of reports describe the methods to 
synthesize monocleavable AB-SS-AB copolymers and their self-assembled 
micelles. For example, a thiol-alkyne click
[37]
 reaction and ROP
[38]
 were used to 
synthesize branched copolymers, while reversible addition-fragmentation chain 
transfer (RAFT) polymerization
[39]
 and atom-transfer radical polymerization 
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(ATRP), as presented in the previous chapter, were explored to synthesize linear 
diblock copolymers. 
 The purpose of the research presented in this chapter was to explore a new 
strategy to synthesize monocleavable micelles consisting of hydrophobic PLA 
and hydrophilic PEO (Figure 4.1). PLA is biocompatible, FDA-approved for 
clinical use, and biodegradable through enzymatic reactions and hydrolysis in 
physiological conditions.
[9, 41, 55]
 The present strategy is based on utilizing PEO 
because it is biocompatible and also FDA-approved for clinical use as well as 
defined by low toxicity.
[86]
 Furthermore, PEO prevents nonspecific protein 
adsorption, thus prolonging blood circulation for PLA-based nanocarriers.
[48, 87]
 
The new strategy is centered on a facile carbodiimide coupling reaction between 
PEO and PLA having a disulfide in the middle, thus PEO-b-PLA-SS-PLA-b-PEO 
ssABP-2. The resulting ssABP-2 copolymers and their self-assembled micelles 
were characterized for reduction-responsive degradation and release of 
encapsulated anti-cancer drugs, as well as non-specific protein adsorption. 
 
Figure 4.1. Synthetic strategy for the preparation of well-controlled reduction-




4.2.1 Instrumentation and analyses  
The details are described in section 3.2.1 of chapter 3 (page 33). 
4.2.2 Transmission Electron Microscope (TEM) images  
TEM images were obtained using a Philips Tecnai 12 TEM, operated at 120 
kV and equipped with a thermionic LaB6 filament. An AMT V601 DVC camera 
with point to point resolution and line resolution of 0.34 nm and 0.20 nm 
respectively was used to capture images at 2048 by 2048 pixels. The specimen 
preparation was carried out as follows, a micellar dispersion was dropped onto a 
copper TEM grid (400 mesh, carbon coated), blotted and allowed to dry at room 
temperature.  
4.2.3 Materials  
Poly(ethylene oxide) methyl ether (PEO) (MW = 2,000 g/mol), 2-
hydroxyethyl disulfide (ssDOH), 3,6-dimethyl-1,4-dioxane-2,5-dione (DL-lactide, 
LA), tin(II) 2-ethylhexanoate (Sn(Oct)2, 95%), succinic anhydride (SA), 
triethylamine (Et3N), 4-(dimethylamino)pyridine (DMAP), N,N-
dicyclohexylcarbodiimide (DCC), Nile Red (NR), L-glutathione reduced (GSH) 




 forms, > 98%) from Aldrich; 
DL-dithiothreitol (DTT, 99%) from Acros Organics; and Bovine Serum Albumin 
(BSA, > 95%) from MP biomedicals were purchased and used as received. 
Dialysis tubing with MWCO = 12,000 Da was purchased from Spectrum Labs.  
4.2.4 Synthesis of ss(PLA-OH)2 by ROP  




4.2.5 Carboxylation of ss(PLA-OH)2 to ss(PLA-COOH)2 
 The purified, dried ssPLA-OH homopolymers were carboxylated by reacting 
with succinic anhydride (50 mole equivalents to hydroxyl groups of ss(PLA-
OH)2) in the presence of Et3N. The purified, dried ss(PLA-OH)2 (2.4 g, 0.25 
mmol), succinic anhydride (1.23 g, 12.3 mmol), and DMAP (15 mg, 0.12 mmol) 
were dissolved in tetrahydrofuran (THF, 20 mL). The resulting mixture was 
purged with N2 for 30 min. Et3N (1.24 g, 12.3 mmol) was added drop-wise for 15 
min and kept at room temperature for 12 hrs. The resulting mixture was 
concentrated by evaporating THF and precipitated from aqueous HCl solution to 
remove excess Et3N and unreacted succinic anhydride. The precipitates were 
dissolved in THF and the precipitation procedure was repeated three times. The 
resulting ss(PLA-COOH)2 precipitates were dried in a vacuum oven at room 
temperature for 12 hrs.  
4.2.6 Synthesis of ssABP-2 by DCC coupling 
 A solution of DCC (0.15 g, 0.70 mmol) in DCM (4 mL) was added drop-
wise to a solution containing ss(PLA-COOH)2 (1.72 g, 0.18 mmol), PEO (0.70 g, 
0.35 mmol), and DMAP (2 mg, 0.018 mmol) in DCM (30 mL) while stirring in an 
ice-bath at 0 C for 20 min under nitrogen atmosphere. The resulting mixture was 
allowed to stir at room temperature for 12 hrs. The dicyclohexylurea (DCU) 
formed as a byproduct was removed by vacuum filtration and DCM was removed 
by evaporation.  
For purification, the residues were dissolved in DMF and dialyzed in 
deionized water for 2 days to remove residual PEO and other starting materials. 
Afterwards, water was removed by rotary evaporation, the polymeric residues 
dissolved in THF, and precipitated from cold MeOH. The residual ss(PLA-
COOH)2 as precipitates were removed by vacuum filtration. The supernatant was 
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evaporated by rotary evaporation, and the remaining residues were dried in a 
vacuum oven at room temperature for 12hrs to yield ssABP-2.  
4.2.7 Determination of critical micellar concentration (CMC) using a NR 
probe  
The details are described in section 3.2.8 of chapter 3 (pages 37-38). 
4.2.8 Aqueous self-assembly  
Deionized water was added drop-wise into organic solutions consisting of the 
purified, dried ssABP-2 dissolved in THF. The resulting dispersions were stirred 
for >12 hrs to remove THF, yielding colloidally stable micellar dispersions at 
various concentrations. For the preparation of micelles at 1 mg/mL, ssABP-2 or 
HS-ABP (10 mg), THF (3 mL), and water (10 mL) were used.  
4.2.9 Reductive cleavage of disulfide linkages in ssABP-2  
Aliquots of the purified, dried ssABP-2 (100 mg, 8.0 mol disulfides) were 
mixed with DTT (100 mg/mL, 77 L, 50 mol) in DMF (5 mL) under stirring. 
Aliquots of the sample were taken periodically for GPC analysis. Upon the 
complete degradation of ssABP-2, the degraded polymer solution in DMF was 
dialyzed in deionized water to remove excess DTT and DMF. Then, the resulting 
aqueous dispersion was analyzed by DLS.  
4.2.10 Reduction-responsive degradation of ssABP-2 micelles  
Aliquots of ssABP-2 micelle dispersions at 5.8 mg/mL (8.6 mL) were mixed 
with a stock solution of DTT in water (1 mg/mL, 132 L, 86 mol). In addition, 
aliquots of ssABP-2 micelle dispersion at 1.3 mg/mL were mixed with a stock 
solution of GSH in water (1mg/mL, 222 μL, 72 μmol). DLS was used to follow 
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changes in micelle size and size distribution. For GPC measurements, water was 
evaporated using rotary evaporation and the dried polymer was dissolved in THF. 
4.2.11 Encapsulation of Dox  
Clear solutions consisting of an aliquot of ssABP-2 (20 mg), Dox (2.0 mg, 
3.45 μmol), Et3N (1.05 mg, 10.38 μmol), and DMF (3 mL) were mixed with 
water (10 mL) and stirred for 2 hrs. The resulting dispersion was dialyzed in 
deionize water (1L) over 24 hrs to form Dox-loaded micelle dispersion at 1.1 
mg/mL. To determine the loading level of Dox by UV/Vis spectroscopy, an 
aliquot of Dox-loaded micellar dispersion (1 mL) was mixed with DMF (5 mL) to 
form a clear solution of DMF/water = 5/1 v/v. The UV/Vis spectrum was 
recorded and the loading level of DOX was calculated by the weight ratio of 
loaded DOX to dried polymers.  
4.2.12 GSH-triggered Dox release from Dox-loaded micelles  
Aliquots of the Dox-loaded micellar dispersion at 1.1 mg/mL (5 mL) was 
transferred into dialysis tubing immersed in PBS containing 10 mM GSH at pH = 
7.4 (60 mL) as well as PBS (pH = 7.4) as a control. The fluorescence spectra of 
the outer water were measured over 46 hrs. To quantify the %Dox released from 
micelles, Dox (0.12 mg, equivalent to Dox encapsulated in 5 mL of Dox-loaded 
micelles) and Et3N (0.06 mg, 3 mol equivalents) were dissolved in PBS (60 mL) 
to measure the fluorescence spectrum.  
4.2.13 Non-specific interaction of ssABP-2 micelles with BSA  
A similar procedure for the aqueous self-assembly described above was 
used to prepare a micellar dispersion of ssABP-2 at 13 mg/mL. Then, an aliquot 
(1 mL) was mixed with two different volumes (1 mL and 2 mL) of an aqueous 
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BSA solution in PBS (13 mg/mL). DLS was used to follow any changes in 




















4.3 Results and discussion   
4.3.1 Synthesis of ssABP-2 
 As illustrated in Figure 4.1, the approach for the synthesis of ssABP-2 (i.e. 
PEO-b-PLA-ss-PLA-b-PEO) triblock copolymers having disulfides in the middle 
of central PLA block consists of three steps. The first step is the synthesis of well-
controlled ss(PLA-OH)2 by ring opening polymerization of LA in the presence of 
Sn(Oct)2 in toluene at 120 C. The polymerization conditions include 
[LA]0/[ssDOH]0/[Sn(Oct)2]0 = 70/1/0.05 and weight ratio of LA/toluene = 1.5/1. 
The detailed procedure is described in the previous chapter. The purified ss(PLA-
OH)2 had the molecular weight Mn = 9,300 g/mol and Mw/Mn = 1.09 determined 
by GPC (Figure 4.2) and the degree of polymerization (DP) = 50 determined by 
1
H-NMR from the integral ratio of peaks (b/d) (Figure 4.3a). The second step 
consists of the facile coupling of ss(PLA-OH)2 with excess succinic anhydride 
(SA) in DMF at room temperature. The resulting ss(PLA-COOH)2 was purified 
by precipitation from water to remove unreacted SA. As seen in Figure 4.3b, a 
new peak at 2.7 ppm (f) corresponding to eight methylene protons in the SA 
moiety appeared, while a peak at 4.3 ppm (e) corresponding to two terminal 
methine protons in ss(PLA-OH)2 disappeared. The integral ratio of peaks (f/d) 









H-NMR spectra of purified ss(PLA-OH)2 (a) and ss(PLA-COOH)2 
(b) in CDCl3. 
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After the successful synthesis and characterization of ss(PLA-COOH)2 
having terminal COOH groups, the third step is a carbodiimide coupling reaction 
of ss(PLA-COOH)2 with PEO under conditions including the initial mole 
equivalent ratio of [OH]0/[COOH]0 = 1/1 in the presence of excess DCC (4 mole 
equivalent to OH groups) in DCM at 0 C for 12 hrs. As seen in Figure B.1, the 
reaction mixture contains ssABP-2 triblock copolymers and also residual PEO 
and ss(PLA-COOH)2. Thus, the resulting triblock copolymer was purified with 
multiple steps including 1) removal of dicyclohexyl urea (a byproduct of the DCC 
coupling reaction) by vacuum filtration and DCM by evaporation; 2) intensive 
dialysis of the resulting polymeric residues dissolved in DMF over water to 
remove residual PEO; 3) lyophilation to remove water; 4) precipitation of the 
residues dissolved in THF from MeOH to remove unreacted ss(PLA-COOH)2 or 
ssPLA species as precipitates; and 5) further evaporation of MeOH. GPC results 
of the purified polymers indicate the clean evolution of GPC trace to high 
molecular weight region, with an increasing Mn = 10,900 g/mol. Furthermore, no 
significant residues of ss(PLA-COOH)2 and PEO remained which suggests the 
purification method was efficient (Figure 4.2). 
1
H-NMR spectrum in Figure 4.4 
shows a new triplet at 4.2 ppm corresponding to the four methylene protons 
adjacent to the ester linkage, confirming the occurrence of coupling reaction 
between COOH group in ss(PLA-COOH)2 and OH group in PEO. From the 
integral ratio of (g/f), the coupling efficiency was determined to be >98%. These 







H-NMR spectrum of ssABP-2 in CDCl3. 
4.3.2 Aqueous micellization of ssABP-2 
 The resulting ssABP-2 triblock copolymer consisting of hydrophilic PEO 
and hydrophobic PLA-ss-PLA blocks is amphiphilic and may self-assemble in 
aqueous solution to form micellar aggregates consisting of hydrophobic PLA core 
surrounded with PEO coronas. First, their critical micellar concentration was 
determined by fluorescence spectroscopy using a NR probe. As seen in Figure 
4.5, the fluorescence (FL) intensity of NR was significantly low and did not 
change at low concentrations of ssABP-2. This is due to a significant amount of 
NR molecules remaining in water because the concentration of ssABP-2 is not 
high enough for the formation of micelles. However, it increased with an 
increasing concentration of ssABP-2. Such FL increase is attributed to the 
formation of ssABP-2 micelles that enable the encapsulation of NR molecules in 












hydrophobic micellar cores. From two linear regressions, the CMC of ssABP-2 
was determined to be 13 g/mL.  
 
Figure 4.5. Overlaid fluorescence spectra (inset) and fluorescence intensity at  = 
620 nm for aqueous mixtures consisting of NR with various amounts of ssABP-2 
to determine the CMC. 
Then, aqueous micellization through self-assembly of ssABP-2 was 
examined at 1.3 mg/mL, above the CMC, using a solvent evaporation method. 
DLS results of the prepared nanoparticles suggests the formation of colloidally 
stable micellar aggregates with a diameter of 21 nm (Figure 4.6a). Furthermore, 
TEM images of the micellar aggregates were obtained to corroborate the DLS 
results and obtain information with regards to the morphology of the partciles. 
The TEM images indicate a diameter of 17 nm with a spherical morphology, 
CMC  = 13 μg/mL 

















































which is smaller than that determined by DLS, due to the dehydrated state of the 
micelles (Figure 4.6b).  
 
Figure 4.6. DLS diagrams (a, c) and TEM images (b, d) of aqueous micelles 
before (a, b) and after (c, d) treatment with 10mM DTT in aqueous solution at 1.3 
mg/mL. 
4.3.3 Thiol-induced degradation of ssABP-2 triblock copolymers 
 In order to characterize the ssABP-2 system for its propensity towards 
thiol-triggered drug release, initial studies were performed to determine the 
response of ssABP-2 triblock copolymer and its self-assembled nanostructures 
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towards reduction reactions. First, the reductive cleavage of disulfides was 
examined under homogeneous conditions. Aliquots of the purified ssABP-2 were 
mixed with DTT in DMF. DTT is commonly used as an amphiphilic reducing 
agent which is soluble in most common organic solvents including DMF. As seen 
in Figure 4.7, the molecular weight rapidly decreased from Mn = 10,800 g/mol to 
Mn = 6,100 g/mol within 1 hr. This decrease in molecular weight results from the 
cleavage of the disulfide linkages in the middle of the central hydrophobic block. 
Following thiol-triggered degradation of ssABP-2 triblock copolymers in DMF, 
the degradation of self-assembled micelles in aqueous solution (heterogeneous 
conditions) was examined. Two reducing agents including DTT and GSH were 
examined, since GSH is a cellular trigger. Aliquots of the micellar dispersions 
were mixed with 10 mM DTT (micelles at 1.3 mg/mL) and 10 mM GSH 
(micelles at 5.8 mg/mL) at room temperature. The change in size was followed 
using DLS. When the micelles were treated with DTT, their diameters gradually 
decreased from 20 nm to 10 nm over a period of 72 hrs (Figure 4.8). Similar 
decrease in size in the presence of DTT has been reported for other mono-
cleavable micelles with different structures of ABPs.
[37-38]
 The degraded products 
were further analyzed using GPC, after the removal of water, in order to correlate 
the change in micelle size to a reduction of the disulfide bond. As seen in Figure 
4.7, the degraded products in the presence of DTT had decreased molecular 
weight to Mn = 6,300 g/mol. This value is similar to that (6,100 g/mol) of the 
degraded products in DMF (homogeneous solution). These results suggest that the 
decrease in micelle size is a consequence of the cleavage of the central disulfide 
linkage in response to DTT, yielding degraded PEO-b-PLA-SH. In a control 
experiment, the degraded products (PEO-b-PLA-SH) in DMF were micellized in 
order to study their size using DLS and the results show that the cleaved shABP-2 
formed smaller-sized nanostructures with a diameter of 10 nm by DLS and 9 nm 
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by TEM (Figure 4.6c). However, their morphologies were not well-defined, as 
seen in TEM image (Figure 4.6d).  
 
Figure 4.7. GPC traces of ssABP-2 before and after treatment with DTT in DMF 
as well as ssABP-2 micelles treated with DTT and GSH in water. For micelle 
sample, water was removed for GPC measurements. 
 
Interestingly, in the presence of GSH (10 mM) the particle size increased 
with an occurrence of larger aggregates (Figure 4.8), which opposes the size 
decrease observed for the DTT-treated micelles. GPC analysis of the degraded 
products in the presence of GSH indicate a decrease in the molecular weight to 
Mn = 9,100 g/mol which is larger than that for the DTT-treated micelle and the 
degraded product in DMF. A proposed degraded product in the presence of GSH 
includes PEO-b-PLA-SS-GSH. The presence of terminal GSH moiety could 
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explain the larger micelle size and the relatively larger molecular weight of the 
degraded product in the presence of GSH. 
 
Figure 4.8. DLS diagram of aqueous ssABP-2-based micelles in the presence of 
10 mM DTT (a) and 10 mM GSH (b) over time. 
4.3.4 Loading and thiol-triggered drug release from Dox-loaded ssABP 
 Dox, a DNA intercalating anticancer drug in chemotherapy, was 
encapsulated in ssABP-2 micelles using a dialysis method. After intensive 
dialysis in deionized water, the prepared Dox-loaded micelles had a concentration 
of 2.4 mg/mL. Using the absorbance at λmax = 497 nm (Figure B.2) and the pre-
determined extinction coefficient, ε = 12,400 M-1cm-1 in a mixture of DMF/water 
= 5/1 v/v,
[53]
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In response to reduction reactions, Dox can be released from Dox-loaded 
micelles and diffuse through the dialysis tubing to the outer water. Therefore, to 
study the thiol-triggered Dox release for the ssABP-2 system, aliquots of Dox-
loaded ssABP-2 were dialyzed in the presence and absence of 10 mM GSH and 
the fluorescence increase of Dox in the outer water was monitored over time. 
Here, the reductive release of encapsulated Dox from micelles was examined 
using fluorescence spectroscopy. In order to eliminate concerns about the 
enhanced degradation of PLA in acidic pH, the pH of the outer was adjusted to 
pH = 7.4 using PBS solution for both control and 10 mM GSH aqueous solution. 
Figure B.3 shows the evolution of fluorescence spectra of outer water (λex = 470 
nm) over time. Using fluorescence intensities at λmax = 590 nm, %Dox release 
over time was constructed in Figure 4.9. In the absence and presence of GSH, the 
gradual Dox release was followed for up to 46 hrs. Compared to the absence of 
GSH as a control, Dox release was enhanced to some degree in the presence of 10 
mM GSH, as a consequence of the destabilization of Dox-loaded micelles upon 





Figure 4.9. % Release profiles of Dox from Dox-loaded micelles in the absence 
(control) and presence of 10 mM GSH in PBS solution adjusted at pH = 7.4. 
4.3.5 Non-specific protein interaction of ssABP-2 in vitro 
 Human serum albumin is one of the most abundant protein in blood serum 
and is found at concentrations ranging from 35-50 g/L. Here, ssABP micellar 
dispersion was incubated with different amounts of bovine serum albumin (BSA) 
at the weight ratio of micelles/BSA = 1/1 (13 g/L) and 1/2 (26 g/L) in PBS 
solution at pH = 7.4 (mimic of physiological conditions). Figure 4.10 shows the 
DLS diagrams of the mixtures after 90 hrs. For the mixtures at micelles/BSA = 
1/1 w/w, a bimodal distribution appeared; each population appeared to be 
identical to ssABP-2 micelles and BSA in PBS solution. Furthermore, no 
occurrence of significant aggregation is observed. Similar results are found for the 






















mixture at micelles/BSA = 1/2 w/w. These results suggest that the presence of the 
hydrophilic PEO coronas provide enhanced colloidal stability to the nanoparticles 
in the presence of proteins during blood circulation and prevents from protein 
adsorption in physiological conditions.  
 
Figure 4.10. DLS diagrams of mixture consisting of ssABP-2 micelles and BSA 
at weight ratio of micelle/BSA = 1/1 (13 mg/mL) and 1/2 (26 mg/mL) in PBS 
solution at pH = 7.4 after 90 hrs. 
4.4 Conclusion 
 New reduction-responsive triblock copolymers (ssABP-2) consisting of 
hydrophobic PLA and hydrophilic PEO blocks were synthesized by a 
combination of ROP and a facile carbodiimide coupling reaction. At 
concentrations above the CMC (13 μg/mL), aqueous self-assembled micelles with 
a diameter of 20 nm degraded to smaller nanostructures with diameter <10 nm in 
the presence of DTT, but to larger aggregates in the presence of GSH. Such 
changes in diameter are the consequence of reductive cleavage of disulfide 
linkages positioned in the middle of the ssABP-2 and forms smaller ABPs (PEO-
b-PLA-SH or PEO-b-PLA-SS-GSH). The reductive-cleavage resulted in the 
destabilization of micelles, leading to the enhanced release of encapsulated 
micelles/BSA 
= 1/2  
Diameter (nm) 
10 100 1 1000 
Micelles/BSAS 
= 1/1 
Dv = 8 nm  Dv = 20 nm  
Dv = 8 nm  
Dv = 25 nm  
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anticancer drugs. For biological perspectives, the ssABP micelles abstain from 
non-specific interaction with BSA proteins up to >90 hrs. These results suggest 
that ssABP and its self-assembled micelles could find their applications as 
reduction-responsive controlled/enhanced drug delivery nanocarriers. Moreover, 
these results show the successful synthetic design for the preparation of PLA-
based monocleavable triblock copolymers with PEO as hydrophilic block, thereby 
expanding the possible combinations of hydrophobic and hydrophilic blocks that 



















Conclusion and future work  
 On the brink of bridging the gap between polymer research and 
pharmaceutical applications as drug delivery carriers, certain missing links awaits 
elucidation. A successful polymer-based drug delivery strategy relies on the use 
of biocompatible material, high encapsulation efficiency, long circulation time, 
and spatio-temporal drug release. With regards to drug release, one approach 
which holds great promise is the SRD platform. In particular, disulfide-thiol 
chemistry proposes a direct method for the controlled/enhanced release of 
encapsulated anticancer therapeutics in specific cells through the exploitation of 
the endogenous redox gradients. Further, careful incorporation of the disulfide 
linkages in the synthesis of well-defined block copolymers allowed for the 
investigation of morphological variance vs. stimuli-responsive drug release. The 
monocleavable system with the cleavable linkage in the middle of the central 
block of triblock copolymer was examined. Although often overlooked, a major 
aspect in the preparation of pharmaceutically exploitable ABP-based drug 
delivery systems is the ease of synthesis and the synthetic reproducibility. 
Furthermore, to expand on the possible combinations of polymers in the 
preparation of amphiphilic block copolymers different synthetic strategies were 
designed which rely on the incorporation of hydrophobic and biocompatible PLA 
with different hydrophilic blocks in a triblock copolymer system. In this thesis, 
two different methods for the preparation of PLA-based monocleavable triblock 
ABPs are proposed and the propensity of these systems towards drug delivery 
applications is presented.  
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 To begin with, well-defined and reduction-responsive ss(PLA-b-
POEOMA)2 triblock copolymers were synthesized by a combination of ROP and 
ATRP. GPC and NMR results suggest that both polymerizations proceeded in a 
living manner allowing for the synthesis of well-defined ss(PLA-OH)2 and 
ssABP-1 with monomodal and narrow molecular weight distribution with Mw/Mn 
< 1.15. Aqueous micellization of these ssABP-1 formed self-assembled micellar 
aggregates with disulfide-containing PLA cores. Because of the presence of 
central disulfides, these polymers degraded in response to thiols upon the 
cleavage of the disulfide linkage. Moreover, the presence of the hydrophobic core 
enabled the encapsulation of Dox as a model hydrophobic therapeutic drug. 
Results show that the thiol-triggered degradation resulted in enhanced release of 
encapsulated anticancer drug.  
 In the second strategy, ss(PLA-b-PEO)2 were obtained through a 
combination of ROP and a facile coupling method. In this method, PEO was used 
as the hydrophilic block due to its promising properties in drug delivery 
applications; a great deal of research has shown the link between the presence of 
PEO as hydrophilic corona and the increase in circulation time as well as the 
reduction of non-specific protein interaction. Moreover, this line of work was 
directed towards discovering a synthetic method enabling the preparation of PLA-
based block copolymers with PEO as the hydrophilic block. GPC and 
1
H-NMR 
results suggest the synthesis of well-defined ssABP with narrow molecular weight 
distribution. These ssABP enabled the preparation of micellar nanoparticles where 
at concentrations above the CMC, 13 μg/mL, self-assembled micelles with a 
diameter of 20 nm are obtained. Due to the presence of thiol-responsive disulfide 
bonds in the core of the micelles, these nanoparticles responded to thiol-reducing 
agents such as GSH and DTT and underwent morphological changes. Indeed, 
these micelles degraded to smaller nanostructures with diameter <10 nm in the 
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presence of DTT, but to larger aggregates in the presence of GSH. Such changes 
in diameter are the consequence of reductive cleavage of disulfide linkages 
positioned in the middle of ssABP-2 and forms smaller ABPs (PEO-b-PLA-SH or 
PEO-b-PLA-SS-GSH). In addition, the reductive-cleavage resulted in the 
destabilization of micelles, leading to the enhanced release of encapsulated 
anticancer drugs. For biological perspectives, the ssABP-2 micelles did not 
exhibit non-specific interaction with BSA proteins for up to >90 hrs.  
 In summary, the present thesis examined different synthetic methods for 
the preparation of monocleavable triblock copolymer micelles with the thiol-
reducing disulfide bond in the middle of the triblock copolymer. Although this 
system presented a certain potential towards drug delivery applications, certain 
improvements are needed. First of all, the monocleavable system exhibits 
reduction-responsive drug release to some degree. One potential solution to 
improve drug release could be the incorporation of multiple disulfide groups into 
the polymer to further disrupt the HS-ABP micelles generated and ensure 
complete drug release. This multicleavable system (shown in Figure 1.4c) 
demonstrates rapid drug release through main-chain cleavage mechanism.
[35a]
 
However, complexity in the design of PLA-related systems can pose a problem. 
Moreover, as mentioned earlier, there exist other parameters that need to be tuned 
for a successful drug delivery system to see the light of day. One prominent 
example is the increase in circulation time for the nanoparticles traveling 
throughout the bloodstream. Indeed, these nanoparticles escape the blood 
circulation and enter cancer tissues through the Enhanced-Permeation and 
Retention (EPR) effect. However, to fully exploit this mechanism and increase the 
uptake in cancer tissues these nanoparticles need to remain in circulation long 
enough to encounter the tumor tissues. A lot of research has shown that PEO as 
hydrophilic block increases residence time while reducing non-specific protein 
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interaction; however more work is needed to determine the exact mechanism of 
this phenomenon for its full exploitation. Finally, a thorough understanding of the 
interaction between the drug and the core forming block is necessary to increase 
drug encapsulation and reduce premature drug release, both important parameters 
governing the pharmacokinetics of the drug delivery system. For example, the 
glass-transition temperature (Tg) of the polymer constituting the core can have an 
impact on the loading and release profile of the encapsulated drug. A polymer 
with a high Tg will be characterized by a crystalline state thereby reducing the 
interactions between the nanocarrier core and the drug, as well as creating a 
network impeding drug diffusion; ultimately, reducing both drug loading and 
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Figure A.1. First-order kinetic plot (a) and evolution of molecular weight and 
molecular weight distribution over conversion (b) for ATRP of OEOMA in the 
presence of ss(PLA-Br)2 macroinitiator in THF at 47 C. Conditions: 
[OEOMA]0/[ss(PLA-Br)2]0/[CuBr/PMDETA]0 = 20/1/0.5; OEOMA/THF = 0.8/1 
wt/wt. The dotted lines are linear fits and the line in (b) is the theoretically 
predicted molecular weight over conversion. 
















































H-NMR spectra, in CDCl3, of ss(PLA-OH)2 (a) and DTT-mediated 
degraded product (HS-PLA-OH) (b) yielded by the cleavage of disulfides. X 
denotes a residure of THF. 
 
Figure A.3. UV/Vis spectrum of Dox-loaded micelles in a mixture of DMF/water 
= 5/1 v/v. 
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Figure A.4. Evolution of fluorescence spectra of outer water in the absence (a) 
and presence (b) of 10 mM GSH along with fluorescence spectra used for 
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Figure B.1. GPC traces of ss(PLA-COOH)2 (a), and PEO (b), and crude ssABP-2 
before purification (c). 
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Figure B.2. UV/Vis spectrum of Dox-loaded micelles in a mixture of DMF/water 
= 5/1 v/v. 
 
Figure B.3. Evolution of fluorescence spectra of outer water in the absence (a) 
and presence (b) of 10 mM GSH along with fluorescence spectra used for 
normalization as a mimic of 100% drug release.  
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